-
4
-
-
0000702133
-
Hypothalamic and other peptide hormones
-
J. F. Holland, E. Frei III, R. C. Bast, Jr., D. E. Kufe, R. E. Pollock, and R. R. Weichselbaum (eds.). Hamilton, Ontario: B. C. Decker, Inc.
-
(2000)
Cancer Medicine, 5th ed.
, pp. 715-729
-
-
Schally, A.V.1
Comaru-Schally, A.M.2
-
8
-
-
0027517429
-
3]-octreotide: The Rotterdam experience with more than 1000 patients
-
(1993)
Eur. J. Nucl. Med.
, vol.20
, pp. 716-731
-
-
Krenning, E.P.1
Kwekkeboom, D.J.2
Bakker, W.H.3
Breeman, W.A.P.4
Kooij, P.P.M.5
Oei, H.Y.6
Van Hagen, M.7
Postema, P.T.E.8
De Jong, M.9
Reubi, J.C.10
Visser, T.J.11
Reijs, A.E.M.12
Hofl, L.J.13
Koper, J.W.14
Lamberts, S.W.J.15
-
11
-
-
0032900726
-
3octreotide (DOTATOC): A pilot study in human gliomas
-
(1999)
Clin. Cancer Res.
, vol.5
, pp. 1025-1033
-
-
Merlo, A.1
Hausmann, O.2
Wasner, M.3
Steiner, P.4
Otte, A.5
Jermann, E.6
Freitag, P.7
Reubi, J.C.8
Müller-Brand, J.9
Gratzl, O.10
Macke, H.R.11
-
13
-
-
9244237087
-
Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer
-
(1996)
Cancer Res.
, vol.56
, pp. 1823-1827
-
-
Buscail, L.1
Saint-Laurent, N.2
Chastre, E.3
Vaillant, J.-C.4
Gespach, C.5
Capella, G.6
Kalthoff, H.7
Lluis, F.8
Vaysse, N.9
Susini, C.10
-
14
-
-
0031025637
-
sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells
-
(1997)
Cancer Res.
, vol.57
, pp. 956-962
-
-
Delesque, N.1
Buscail, L.2
Esteve, J.-P.3
Saint-Laurent, N.4
Muller, C.5
Weckbecker, G.6
Bruns, C.7
Vaysse, N.8
Susini, C.9
-
16
-
-
0032483743
-
Expression of human somatostatin receptor subtype 3 in pancreatic cancer in vitro and in vivo
-
(1998)
J. Natl. Cancer Inst. (Bethesda)
, vol.90
, pp. 1666-1668
-
-
Raderer, M.1
Pangerl, T.2
Leimer, M.3
Valencak, J.4
Kurtaran, A.5
Hamilton, G.6
Scheithauer, W.7
Virgolini, I.8
-
18
-
-
0029822870
-
Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide
-
(1996)
Surgery (St. Louis)
, vol.120
, pp. 234-240
-
-
Fisher, W.E.1
Muscarela, P.2
O'Dorisimo, T.M.3
O'Dorisimo, M.S.4
Kim, J.A.5
Doran, T.A.6
Sabourin, C.L.7
Schirmer, W.J.8
-
19
-
-
0032950730
-
Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: In vitro and in vivo results. Br
-
(1999)
Br. J. Cancer
, vol.79
, pp. 535-537
-
-
Raderer, M.1
Hamilton, G.2
Kurtaran, A.3
Valencak, J.4
Hoffman, O.5
Kornek, G.V.6
Vorbeck, F.7
Hejna, M.H.L.8
Virgolini, I.9
Scheithauer, W.10
-
21
-
-
0032539609
-
Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolino-doxorubicin
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 1794-1799
-
-
Nagy, A.1
Schally, A.V.2
Halmos, G.3
Armatis, P.4
Cai, R.-Z.5
Csernus, V.6
Kovacs, M.7
Koppan, M.8
Szepeshazi, K.9
Kahan, Z.10
-
25
-
-
0032816763
-
Inhibition of growth of MX-1, MCF-7-MIII and MDAMB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238
-
(1999)
Int. J. Cancer
, vol.82
, pp. 592-598
-
-
Kahan, Z.1
Nagy, A.2
Schally, A.V.3
Hebert, F.4
Sun, B.5
Groot, K.6
Halmos, G.7
-
36
-
-
17444441370
-
3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies
-
(1998)
Clin. Cancer Res.
, vol.4
, pp. 2047-2052
-
-
Schulz, S.1
Schulz, S.2
Schmitt, J.3
Wiborny, D.4
Schmidt, H.5
Olbricht, S.6
Weise, W.7
Roessner, A.8
Gramsch, C.9
Höllt, V.10
-
41
-
-
2642657309
-
Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829
-
(1998)
Cancer Res.
, vol.58
, pp. 1850-1859
-
-
Virgolini, I.1
Leimer, M.2
Handmaker, H.3
Lastoria, S.4
Bischof, C.5
Muto, P.6
Pengerl, T.7
Gludovacz, D.8
Peck-Radosavljevic, M.9
Lister-James, J.10
Hamilton, G.11
Kaserer, K.12
Valent, P.13
Dean, R.14
-
43
-
-
0034681171
-
Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: Implications for the design of preclinical studies
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 829-834
-
-
Nagy, A.1
Plonowski, A.2
Schally, A.V.3
-
44
-
-
0344500650
-
A Phase II study of high-dose octreotide in patients with unresectable pancreatic carcinoma
-
(1999)
Eur. J. Cancer
, vol.35
, pp. 1805-1808
-
-
Sulkowski, U.1
Büchler, M.2
Pederzoli, P.3
Arnold, R.4
Dinse, P.5
Kay, A.6
Haus, U.7
Beget, H.G.8
-
45
-
-
0033822686
-
Phase III Evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: A North Central Cancer Treatment Group Study
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 3486-3492
-
-
Burch, P.A.1
Block, M.2
Schroeder, G.3
Kugler, J.W.4
Sargent, D.J.5
Braich, T.A.6
Mailliard, J.A.7
Michalak, J.C.8
Hatfield, A.K.9
Wright, K.10
Kuross, S.A.11
|